Iron status in association with cardiovascular disease risk in 3 controlled feeding studies

American Journal of Clinical Nutrition

Volumn 77, Issue 1, 2003, Pages 56-62

  Derstine, Jessica L ^a   Murray Kolb, Laura E ^a   Yu Poth, Shaomei ^a   Hargrove, Rebecca L ^a   Kris Etherton, Penny M ^a   Beard, John L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Conjugated dienes; Ferritin; Iron; Lag time; LDL oxidation; Lipids; TIBC; Total iron binding capacity

Indexed keywords

IRON; LOW DENSITY LIPOPROTEIN; OLIVE OIL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEEDING; FEMALE; FOOD COMPOSITION; HUMAN; HUMAN EXPERIMENT; IRON STORAGE; LIPID OXIDATION; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ARACHIS HYPOGAEA;

EID: 0037215311     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/77.1.56     Document Type: Article

References (47)

1. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-y follow-up of the Framingham population. Am Heart J 1986;111:383-90.
2. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol 1983;117:165-72.
3. Looker AC, Gunter EW, Cook JD, Green R, Harris JW. Comparing serum ferritin values from different population surveys. Vital Health Stat 2 1991;111:1-19.
4. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-88.
5. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293-4.
6. Gillum RF. Body iron stores and atherosclerosis. Circulation 1997; 96:3261-3.
7. McCord JM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation 1991;83:1112-4.
8. Halliwell B, Gutteridge JM. Biologically relevant metal ion-dependent hydroxyl radical generation. An update. FEBS Lett 1992;307: 108-12.
9. Araujo JA, Romano EL, Brito BE, et al. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995;15:1172-80.
10. Yuan XM, Brunk UT, Olsson AG. Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vasc Biol 1995;15:1345-51.
11. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984;74:1890-4.
12. Gutteridge JM, Halliwell B. Comments on review of Free Radicals in Biology and Medicine, second edition, by Barry Halliwell and John M. C. Gutteridge. Free Radic Biol Med 1992;12:93-5 (letter).
13. Dorrepaal CA, Berger HM, Benders MJ, van Zoeren-Grobben D, Van de Bor M, VanBel F. Nonprotein-bound iron in postasphyxial reperfusion injury of the newborn. Pediatrics 1996;98:883-9.
14. Halat G, Chavko M, Lukacova N, Kluchova D, Marsala J. Effect of partial ischemia on phospholipids and postischemic lipid peroxidation in rabbit spinal cord. Neurochem Res 1989;14:1089-97.
15. Magnusson MK, Sigfusson N, Sigvaldason H, Johannesson GM, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102-8.
16. Aronow WS. Plasma ferritin is not a risk factor for coronary artery disease in men and women aged ≥62 y. Am J Cardiol 1993;72: 347-8.
17. Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995;141:719-23.
18. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330: 1119-24.
19. Liao Y, Cooper RS, McGee DL. Iron status and coronary heart disease: Negative findings from the NHANES I epidlemiologic follow-up study. Am J Epidemiol 1994;139:704-12.
20. Berry EM. Growdon JH, Wurtman JJ, Caballero B, Wurtman RJ. Effects of diets rich in monounsaturated fatty acids on plasma lipoprotein - The Jerusalem Nutrition Study: High MUFAs versus high PUFAs. Am J Clin Nutr 1991;53:899-907.
21. Berry EM, Eisenberg S, Friedlander Y, et al Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - The Jerusalem Nutrition Study. II. Monounsaturated fatty acids versus carbohydrates. Am J Clin Nutr 1992;56:394-403.
22. Lahoz C, Alonso R, Porres A, Mata P. Effects of dietary fat saturation on levels of plasma lipoprotein (a) and lipids. Med Clin (Barc) 1998;110:641-5.
23. Mata P, Lopez-Miranda J, Pocovi M, et al. Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 1998;137:367-76.
24. Bonanome A, Pagnan A, Biffanti S, et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb 1992;12:529-33.
25. Reaven P, Parthasarathy S, Grasse BJ, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr 1991;54:701-6.
26. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-76.
27. Ginsberg HN. New directions in dietary studies and heart disease: The National Heart, Lung and Blood Institute sponsored Multicenter Study of Diet Effects on Lipoproteins and Thrombogenic Activity. Adv Exp Med Biol 1995;369:241-7.
28. Kris-Etherton PM, Etherton TD, Peason TA, et al. Stanol-supplemented margarine (SM) lowers LDL-C in moderately hypercholesterolemic subjects fed an average American diet (AAD). FASEB J 1998;12: 1203 (abstr).
29. Pearson TA, Etherton TD, Moriarty K, Reed R, Kris-Etherton PM. High MUFA diets with peanuts-peanut butter (P/PB) or peanut oil (PO) lower total cholesterol (TC) and LDL-C identically to a step 2 diet but eliminate the triacylglycerol (TG) increase. FASEB J 1998; 12:2943 (abstr).
30. Esterbauer H, Striegl G, Puhl H, Potheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
31. Jiang ZY, Hunt JV, Wolff SP, Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992;202:384-9.
32. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27:681-7.
33. Zhang D, Okada S, Kawabata T, Yasuda T. An improved simple colorimetric method for quantitation of non-transferrin-bound iron in plasma. Biochem Mol Biol Int 1995;35:635-41.
34. Fuhrman B, Oiknine J. Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 1994; 111:65-78.
35. Salonen JT, Korpela H, Nyyssonen K, et al. Lowering of body iron stores by blood letting and oxidation resistance of plasma lipoproteins: A randomized cross-over trial in male smokers. J Intern Med 1995;237:161-8.
36. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 1997;314:793-4.
37. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: The epidemiologic data. Nutr Rev 1996;54:73-84.
38. Rauramaa. R, Vaisanen S, Mercuri M, Rankinen T, Penttila I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. Eur Heart J 1994;15: 1020-7.
39. Ascherio A, Willett WC, Rimm EB, Giovanucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994;89:969-74.
40. Danesh J, Appleby P. Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation 1999;99:852-4.
41. Biemond P, Swaak AJ., Beindorff CM, Koster JF. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Implications for oxygen-free-radical-induced tissue destruction during ischaemia and inflammation. Biochem J 1986; 239:169-73.
42. Halliwell B. Free radicals, reactive oxygen species and human disease: A critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989;70:737-57.
43. Pootrakul P, Josephson B, Huebers HA, Finch CA. Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron. Blood 1988;71:1120-3.
44. Fargion S, Cappellini MD, Sampiertro M, Fiorelli G. Non-specific iron in patients with β-thalassaemia trait and chronic active hepatitis. Scand J Haematol 1981;26:161-7.
45. Mata P, Garrido JA, Ordovas JM, et al. Effect of dietary monounsaturated fatty acids on plasma lipoproteins and apolipoproteins in women. Am J Clin Nutr 1992;56:77-83.
46. Grundy SM, Denke MA. Dietary influences on plasma lipids and lipoproteins. J Lipid Res 1990;31:1149-72.
47. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A 1990;87: 3894-8.